Ineke Rijnhout, will create relationships with life science investors, build a strong patent portfolio, and perform an in-depth  market analysis. Together with GYM’s teams of excellence, Ineke Rijnhout is designing a business strategy, including a clinical development roadmap, to accelerate the development of a groundbreaking cell therapy for genetic muscle disorders for which currently no treatment exists.